Prolonged rhythm monitoring using a subcutaneous insertable cardiac monitor (ICM) has proven to be of incremental diagnostic value for a wide spectrum of indications, especially in patients with recurrent unexplained syncope. The aim of the present thesis (Part I) was to investigate the clinical value of ICMs as part of risk stratification in different patients with inherited and/or structural heart disease who are susceptible to sudden cardiac death (SCD) but who do not have a clear indication for an implantable cardioverter-defibrillator (ICD) for primary prevention. Furthermore, given the fact that the majority of patients with inherited and/or structural heart disease are young and do not require bradycardia pacing or resynchronization therapy, we wanted to investigate their suitability for a completely subcutaneous ICD system (Part II).

, , , ,
J.W. Roos-Hesselink (Jolien) , F. Zijlstra (Felix) , S.C. Yap (Sing-Chien)
Erasmus University Rotterdam
Department of Cardiology

Sakhi, R. (2020, December 8). Detection of ventricular arrhytthmias: "Evaluation of cardiac monitors and subcutaneous defibrillators". Retrieved from